Tingley Whittemore
Chief Medical Officer
Tingley Whittemore has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 12, 2026.
On the most recent filing, Tingley Whittemore is listed as Chief Medical Officer at Tenaya Therapeutics, Inc. Inside the rolling window, Tingley Whittemore reported no open-market purchases and 4 open-market sales totaling $13K in TNYA. The largest disclosed transaction in the window is a sale of 5,787 TNYA shares on Aug 17, 2026, worth $4K.
Companies traded
Other insiders at TNYA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tingley Whittemore made?
Tingley Whittemore has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Tingley Whittemore trade?
Tingley Whittemore has filed SEC Form 4 disclosures for 1 company, including TNYA.
When was Tingley Whittemore's most recent SEC Form 4 filing?
Tingley Whittemore's most recent SEC Form 4 filing on Tracefour is dated Sep 12, 2026.
What is Tingley Whittemore's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tingley Whittemore is listed as Chief Medical Officer.
What is Tingley Whittemore's total buy and sell value in the current window?
Inside the rolling retention window, Tingley Whittemore bought $0 and sold $13K based on SEC Form 4 filings.
What was Tingley Whittemore's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,787 TNYA shares on 2026-08-17, worth $4K, per SEC Form 4 filings.